Arkolith/Insider Trading/BTTX/Form 4

Heinen Mark

See RemarksBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Apr 4, 2022
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Buy(P)5K$1.98$10K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2022Grant(A)33K—$033K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-013344) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML